GE HealthCare Technologies (NASDAQ:GEHC) Sets New 12-Month Low - Should You Sell?

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) shares hit a new 52-week low on Thursday . The company traded as low as $71.42 and last traded at $71.36, with a volume of 2240633 shares traded. The stock had previously closed at $79.36.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Citigroup increased their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price target for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $97.73.

GE HealthCare Technologies Trading Down 3.7 %

The business's 50-day moving average is $84.85 and its two-hundred day moving average is $85.20. The stock has a market capitalization of $26.87 billion, a PE ratio of 13.57, a PEG ratio of 3.19 and a beta of 1.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.24%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.

Institutional Investors Weigh In On GE HealthCare Technologies

Several institutional investors have recently bought and sold shares of GEHC. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 4.5% during the fourth quarter. Capital Research Global Investors now owns 60,832,004 shares of the company's stock worth $4,755,851,000 after purchasing an additional 2,608,066 shares in the last quarter. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 4.3% during the fourth quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock valued at $4,107,378,000 after buying an additional 2,155,429 shares in the last quarter. Geode Capital Management LLC grew its holdings in GE HealthCare Technologies by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 11,320,576 shares of the company's stock worth $882,777,000 after acquiring an additional 342,819 shares during the period. Invesco Ltd. lifted its holdings in GE HealthCare Technologies by 18.4% in the 4th quarter. Invesco Ltd. now owns 8,067,927 shares of the company's stock valued at $630,751,000 after acquiring an additional 1,252,613 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $488,531,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.